Related Experiment Video
Updated: May 31, 2025

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Management of Recurrent Ventriculoperitoneal Shunt Infections in Adult Patients
Neval Elgormus1, Yusuf Elgormus2, Bagnu Dundar3
1Department of Microbiology, Faculty of Medicine, Istanbul Atlas University, 34303 Istanbul, Turkey.
Recurrent ventriculoperitoneal shunt (VPS) infections are often caused by resistant Gram-negative bacteria. Early monitoring and tailored antibiotic strategies, including carbapenem combinations, are crucial for managing these challenging VPS infections.
Area of Science:
- Neurosurgery
- Infectious Diseases
- Microbiology
Background:
- Ventriculoperitoneal shunt (VPS) infections pose a significant challenge in managing hydrocephalus.
- Understanding the microbiological and clinical factors associated with single (SVPS) and recurrent (RVPS) VPS infections is critical for effective treatment.
Purpose of the Study:
- To analyze the demographic, clinical, laboratory, and microbiological characteristics of VPS infections.
- To investigate bacterial agents and antibiotic susceptibility in SVPS and RVPS infections.
- To identify risk factors for recurrent VPS infections and evaluate treatment outcomes.
Main Methods:
- A 13-year retrospective study involving 110 patients with SVPS infections and 55 patients with RVPS infections.
- Analysis of bacterial pathogens, antibiotic susceptibility, and treatment regimens.
- Identification of clinical and laboratory parameters associated with infection recurrence.
Main Results:
- Gram-negative organisms were predominant in multiple infections (60%).
- High resistance rates were observed for third-generation cephalosporins (85.2%) and piperacillin-tazobactam (83.3%), with lower resistance to carbapenem (10.4%).
- Risk factors for RVPS included CNS tuberculosis, short antibiotic duration, high CSF/blood protein levels, and prolonged prophylactic antibiotics. A two-stage shunt replacement reduced recurrence.
Conclusions:
- Close monitoring of patients with identified risk factors for RVPS is essential.
- Empirical treatment should consider glycopeptide plus carbapenem due to resistant Gram-negative bacteria.
- Treatment strategies, such as third-generation cephalosporins plus glycopeptide, require revision based on clinical and microbiological data.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

